Discover Tenders by Parts Sleepers Sector

Find the most relevant tenders for Parts Sleepers. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Parts Sleepers tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Parts Sleepers tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion As Part Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 4079862

EMD:Ref Document

Bid Value: Ref Document

424 Days Left

Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Follitropin Alfa Ovaleap

Deadline: 10 Feb 2026

Germany

Ref. No.: 4076239

EMD:Ref Document

Bid Value: Ref Document

100 Days Left

Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Follitropin Alfa Gonal F

Deadline: 10 Feb 2026

Germany

Ref. No.: 4071836

EMD:Ref Document

Bid Value: Ref Document

100 Days Left

Contract Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Follitropin Alfa Bemfola

Deadline: 10 Feb 2026

Germany

Ref. No.: 4070882

EMD:Ref Document

Bid Value: Ref Document

100 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Haloperidol N05Ad01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3999046

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mesalazine A07Ec02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3998161

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Testosterone G03Ba03 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3997903

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Carbamazepine N03Af01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3995591

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Palonosetron A04Aa05 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3992888

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 3979420

EMD:Ref Document

Bid Value: Ref Document

587 Days Left

Freesol Broad Agency Annoucement

Deadline: 22 Feb 2029

United States

Ref. No.: 3975293

EMD:Ref Document

Bid Value: Ref Document

1208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Film Coated Tablets Excluding Potency 2 5Mg As Part Of A So Calle

Deadline: 31 Jan 2026

Germany

Ref. No.: 3943332

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Adalimumab L04Ab04 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940896

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Infliximab L04Ab02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940617

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredient Rivaroxaban B01Af01 With An Effective Strength Of 2 5 Mg Per Divided Dosage Form

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940204

EMD:Ref Document

Bid Value: Ref Document

90 Days Left

Showing 60796 to 60810 of 60885 results

‹
1
2
...
4050
4051
4052
4053
4054
4055
4056
4057
4058
4059
›

Discover Tenders by Parts Sleepers Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Parts Sleepers Sector

Filter Your Search

FREE Trial plan for all new users!